NFSG
PAVM icon

Newbridge Financial Services Group’s PAVmed PAVM Stock Holding History

Newbridge Financial Services Group’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4
Closed -$287 – 1194
2024
Q1 		$287 Buy
+4
New +$302 ﹤0.01% 1113
2023
Q4 		– Sell
-4
Closed -$589 – 1284
2023
Q3 		$589 Buy
+4
New +$620 ﹤0.01% 1193

Other funds holding PAVM

First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
XF
XML Financial Bethesda, Maryland $1.24B AUM 20.4% 1-Year Est. Return

Newbridge Financial Services Group's PAVM Position: Q2 2024 in Review

Newbridge Financial Services Group sold out of PAVmed (PAVM) in Q2 2024, closing a stake of 4 shares — an estimated $287 sold.

Newbridge Financial Services Group first reported a position in PAVM in Q3 2023 and held it in 2 quarters. The position peaked at $589 in Q3 2023. 22 funds tracked by Wall St. Rank hold PAVM as of Q2 2024.

  • Newbridge Financial Services Group reported no remaining PAVmed position as of Q2 2024 after selling out during the quarter.
  • Newbridge Financial Services Group sold 4 PAVmed shares in Q2 2024, an estimated $287.
  • Newbridge Financial Services Group first reported a position in PAVmed in Q3 2023 and held it in 2 quarters.
  • Newbridge Financial Services Group's PAVmed position peaked at $589 in Q3 2023.
  • 22 funds tracked by Wall St. Rank held PAVmed as of Q2 2024.

Based on Newbridge Financial Services Group's 13F filing for Q2 2024, filed 11 Sep 2024.